Significance of M2 macrophage in tubulointerstitial disease secondary to primary Sjogren's disease
Authors:
Open Access
- 15 October 2018
- journal article
- research article
- Published by Taylor & Francis in Renal Failure
- Vol. 40 (1) , 634-639
Abstract
Objective: M2 Macrophages could improve tubulointerstitial disease in animal models. HIF-1αpromotes macrophage polarization and is involved in tubular injury. The study aims to observe the clinicopathologic significance of M2 macrophage and HIF-1α in tubulointerstitial injury secondary to primary Sjogren's disease. Methods: Renal tissue samples from patients with tubulointerstitial disease secondary to primary Sjogren's disease (SS, n = 10), chronic tubulointerstitial nephritis secondary to drug (CIN, n = 8) were included in this study. The expression of CD163, CD68 and HIF-1α were examined by immunohistochemistry or immunofluorescence. Results: (1) Renal involvement was the first manifestation in seven of ten (7/10) patients with pSS, including proteinuria, renal dysfunction, renal tubular acidosis and multiple renal stone; and two patient had intractable hypokalemia. (2) There were numerous CD163- positive cells and CD68- positive cells infiltration in tubulointerstitial injury of pSS, especially in patients with hypokalemia. CD163 positive cells and HIF-1αwere mainly expressed in acute tubulointerstitial injury of pSS, which positively correlated to N-acetyl-β-D-glucosaminidase and β2-microglobulin. (3) Compared with CIN, patients with pSS had higher serum globulin level, erythrocyte sedimentation rate (ESR) and lower urinary osmotic pressure. (4) During follow-up of one year, six patients with pSS and acute tubular injury acquired improved renal function on therapy of steroid and total glucosides of peony. The remaining four patients with pSS had stable renal function. Conclusion: M2 macrophages are involved in acute tubular injury in patients with primary Sjogren's disease. Early intervention can improve renal function of tubulointerstitial injury secondary to primary Sjogren's disease.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (JUSRP11753)
- Science and technology development of Wuxi (CSE31N1601)
This publication has 18 references indexed in Scilit:
- Discrete functions of M 2a and M 2c macrophage subsets determine their relative efficacy in treating chronic kidney diseaseKidney International, 2013
- Critical Involvement of Macrophage Infiltration in the Development of Sjögren's Syndrome–Associated Dry EyeThe American Journal of Pathology, 2012
- Hypoxia Inducible Factor 1-Alpha (HIF-1 Alpha) Is Induced during Reperfusion after Renal Ischemia and Is Critical for Proximal Tubule Cell SurvivalPLOS ONE, 2012
- Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosisKidney International, 2011
- Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: Macrophage harbingers of disease severityArthritis & Rheumatism, 2011
- Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidneyNephrology Dialysis Transplantation, 2009
- Macrophage diversity in renal injury and repairJournal of Clinical Investigation, 2008
- Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injuryThe Journal of Pathology, 2007
- A role of the macrophage in Sjögen's syndrome?Scandinavian Journal of Rheumatology, 2003
- Local macrophage proliferation in human glomerulonephritisKidney International, 1998